Sakai Chemical Industry Co., Ltd. announces an Equity Buyback for 900,000 shares, representing 5.34% for ¥1,500 million.
October 12, 2021 at 07:30 am
Share
Sakai Chemical Industry Co., Ltd. (TSE:4078) announces a share repurchase program. Under the program, the company will repurchase up to 900,000 shares, representing 5.34% of its share capital, for ¥1,500 million. The company will repurchase its shares in order to eliminate cross-shareholdings, expand the shareholder base and improve liquidity, as well as strengthening corporate governance and improving shareholder value. The repurchased shares will be sold. The share repurchase program will run until March 31, 2022 . As of September 30, 2021, the company had 16,855,200 shares outstanding (excluding treasury shares) and 144,800 shares in treasury.
SAKAI CHEMICAL INDUSTRY CO., LTD. is a Japan-based company principally manufactures and sells chemical industry products. The Company operates in two business segments. Chemical segment is involved in the manufacture and sale of chemical products. Main products include titanium products, resin additives, barium products, catalyst products, electronic materials, zinc products, functional materials, and other chemicals such as organophosphorus compounds, organic sulfur compounds, as well as water treatment agents, among others. Medical segment is involved in the manufacture and sale of pharmaceuticals and quasi drugs. Main products include barium X-ray contrast media, medical drugs for peptic ulcer & reflux esophagitis, general drugs such as cold and gastrointestinal drugs, functional foods, as well as other products such as medical devices, among others.